In a research report published Monday, Chardan Capital analyst James McIlree downgraded shares of Globalstar, Inc. (NYSEMKT:GSAT) from Buy to Neutral, citing increased risks of ultimate …
Chardan Capital analysts are weighing in today on satellite company Globalstar, Inc. (NYSEMKT:GSAT) and drug maker Lion Biotechnologies Inc (NASDAQ:LBIO), as both stocks turned extremely volatile on the …
Healthcare analysts shed light on vaccine maker Novavax, Inc. (NASDAQ:NVAX), and Israeli biotech firm Can-Fite Biopharma Ltd (NYSE:CANF).
A strong earnings report from Ambarella Inc (NASDAQ:AMBA) was overshadowed by weak guidance, causing one analyst to remain on the sidelines until the …
Analysts are weighing in on action camera company GoPro Inc (NASDAQ:GPRO) and semiconductor company Ambarella Inc (NASDAQ:AMBA), following GoPro’s negative pre-announcement, which should weigh on Ambarella. Shares of …
While the iShares Nasdaq Biotechnology (IBB) fell nearly 4% today, biotech companies Dynavax Technologies Corporation (NASDAQ:DVAX) and Uniqure NV (NASDAQ:QURE) climbed sharply higher after presenting …
In a research report issued today, Chardan Capital analyst Keay Nakae reiterated a Buy rating on shares of StemCells Inc (NASDAQ:STEM), with a price …
Chardan Capital analyst Gbola Amusa weighed in today with a favorable report on La Jolla Pharmaceutical Company (NASDAQ:LJPC), reiterating a Buy rating and raising the price target …
In a research report released today, Chardan Capital analyst Gbola Amusa downgraded shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) from a Buy to a Hold raring, while …
Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares shot up 56% to $20.75 in pre-market trading after the FDA agreed to allow Aerie to change the …
